<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pathogenesis of <z:hpo ids='HP_0001297'>stroke</z:hpo> involves <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and excitotoxicity, which is mediated in part by neuronal NO synthase (nNOS) activation </plain></SENT>
<SENT sid="1" pm="."><plain>Ghrelin, an endogenous 28-amino acid <z:chebi fb="7" ids="16670">peptide</z:chebi>, is shown to exert antiapoptotic and anti-inflammatory properties </plain></SENT>
<SENT sid="2" pm="."><plain>However, the effect of ghrelin in permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and the role of the vagus nerve in its action remain unknown </plain></SENT>
<SENT sid="3" pm="."><plain>To study this, male adult Sprague-Dawley rats underwent right-sided permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) with or without prior bilateral truncal vagotomy </plain></SENT>
<SENT sid="4" pm="."><plain>This was followed by infusion of 4 nmol human ghrelin as treatment or saline as vehicle </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological deficit was assessed at 24 h after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>Rats were killed thereafter, and brains were rapidly removed and analyzed for <z:mpath ids='MPATH_124'>infarct</z:mpath> size, markers of <z:mp ids='MP_0001845'>inflammation</z:mp>, excitotoxicity, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with vehicle treatment, human ghrelin treatment in vagus nerve-intact rats after MCAO showed marked reduction in neurological deficit by 57% and <z:mpath ids='MPATH_124'>infarct</z:mpath> size by 25% </plain></SENT>
<SENT sid="8" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulted in increases in cerebral TNF-α, IL-6, neutrophil trafficking, matrix metalloproteinase 9 and nNOS gene expression, nitrotyrosine, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Human ghrelin treatment in vagus nerve-intact rats significantly decreased the above measurements </plain></SENT>
<SENT sid="10" pm="."><plain>Human ghrelin treatment also improved 7-day survival and significantly decreased neurological deficit over the entire 7 days after MCAO in vagus nerve-intact rats compared with vehicle </plain></SENT>
<SENT sid="11" pm="."><plain>Prior vagotomy, however, blunted human ghrelin's neuroprotective effects on neurological deficit, <z:mpath ids='MPATH_124'>infarct</z:mpath> size, TNF-α, neutrophil trafficking, nitrotyrosine, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Human ghrelin is thus a neuroprotective agent that inhibits <z:mp ids='MP_0001845'>inflammation</z:mp>, nNOS activity, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> through a vagal pathway </plain></SENT>
</text></document>